trending Market Intelligence /marketintelligence/en/news-insights/trending/3m-k14cy5d9-dn2iqiwpjw2 content esgSubNav
In This List

Mustang Bio appoints chief scientific officer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Mustang Bio appoints chief scientific officer

New York-based Mustang Bio Inc. named Sadik Kassim chief scientific officer.

Kassim has been with the company since March 2017 as vice president of process and analytical development.

Prior to joining the company, he served as the head of analytical development for Novartis AG's cell and gene therapies unit.

Mustang Bio, a subsidiary of Fortress Biotech Inc., also appointed Knut Niss chief technology officer.

Niss joined Mustang in March 2017 as vice president of operations, where he initiated and oversees the establishment of Mustang's cell therapy manufacturing facility.